WNT Signaling as a Therapeutic Target for Glioblastoma.

Authors

Michael Latour, Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USAFollow
Nam-Gu Her
Santosh Kesari, Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USAFollow
Elmar Nurmemmedov, Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USAFollow

Document Type

Article

Publication Date

8-5-2021

Publication Title

Int J Mol Sci

Keywords

california; los angeles; santa monica; jwci; sjci; psjhc

Abstract

The WNT (Wingless/Integrated) signaling pathway is implicated in various stages of glioblastoma, which is an aggressive brain tumor for which therapeutic options are limited. WNT has been recognized as a hallmark of therapeutic challenge due to its context-dependent role and critical function in healthy tissue homeostasis. In this review, we deeply scrutinize the WNT signaling pathway and its involvement in the genesis of glioblastoma as well as its acquired therapy resistance. We also provide an analysis of the WNT pathway in terms of its therapeutic importance in addition to an overview of the current targeted therapies under clinical investigation.

Clinical Institute

Cancer

Department

Oncology

Recommended Citation

Latour, Michael; Her, Nam-Gu; Kesari, Santosh; and Nurmemmedov, Elmar, "WNT Signaling as a Therapeutic Target for Glioblastoma." (2021). Articles, Abstracts, and Reports. 5147.
https://digitalcommons.providence.org/publications/5147